Financial statement analysis and common stock valuation
If you are an investor who values fundamental analysis, you are in the right place. If you need comprehensive financial ratios, read on. You already know that the analysis of financial statements allows you to buy cheap and sell high, now it’s time to put it into practice. Stock Analysis on Net is here for you.
Example company for today:
Regeneron Pharmaceuticals Inc. (NASDAQ:REGN)
Long-term Trends
Analysis of Long-term (Investment) Activity Ratios
Quarterly Data
Measures how efficiently Regeneron Pharmaceuticals Inc. generates revenues from its investments in fixed or total assets.
Income Statement
The income statement (statement of earnings) reports on the performance of Regeneron Pharmaceuticals Inc., the result of its operating activities.
Aggregate Accruals
Financial reporting quality relates to the accuracy with which Regeneron Pharmaceuticals Inc. reported financial statements reflect its operating performance and to their usefulness for forecasting future cash flows.
Aggregate accruals deriving measures of the accrual component of Regeneron Pharmaceuticals Inc. earnings.
Analysis of Long-term (Investment) Activity Ratios
Measures how efficiently Regeneron Pharmaceuticals Inc. generates revenues from its investments in fixed or total assets.
Balance Sheet: Assets
Quarterly Data
The assets reports major classes and amounts of resources owned or controlled by Regeneron Pharmaceuticals Inc..
Common-Size Income Statement
Income statement components (revenues and expenses) shown as percentage of total sales.
Cash Flow Statement
The cash flow statement provides information about Regeneron Pharmaceuticals Inc. cash receipts and cash payments during an accounting period, showing how these cash flows link the ending cash balance to the beginning balance shown on Regeneron Pharmaceuticals Inc. balance sheet.
Balance Sheet: Liabilities and Stockholders’ Equity
Quarterly Data
The liabilities and stockholders’ equity reports major classes and amounts of external claims on assets and owners’ capital contributions, and other internally generated sources of capital.
Statement of Comprehensive Income
Comprehensive income is the change in equity (net assets) of Regeneron Pharmaceuticals Inc. during a period from transactions and other events and circumstances from non-owners sources. It includes all changes in equity during a period except those resulting from investments by owners and distributions to owners.
Balance Sheet: Liabilities and Stockholders’ Equity
The liabilities and stockholders’ equity reports major classes and amounts of external claims on assets and owners’ capital contributions, and other internally generated sources of capital.
Analysis of Solvency Ratios
Quarterly Data
Examines Regeneron Pharmaceuticals Inc. capital structure in terms of the mix of its financing sources and the ability of the firm to satisfy its longer-term debt and investment obligations.
What’s new
Friday, September 11, 2026
Oracle Corp. (NYSE:ORCL) quarterly report
for quarterly period ended August 31, 2026
Thursday, September 10, 2026
Palo Alto Networks Inc. (NASDAQ:PANW) annual report
for fiscal year ended July 31, 2026
Thursday, September 10, 2026
Broadcom Inc. (NASDAQ:AVGO) quarterly report
for quarterly period ended August 2, 2026
Wednesday, September 9, 2026
Intuit Inc. (NASDAQ:INTU) annual report
for fiscal year ended July 31, 2026
Tuesday, September 8, 2026
Dell Technologies Inc. (NYSE:DELL) quarterly report
for quarterly period ended July 31, 2026
Thursday, September 3, 2026
Medtronic PLC (NYSE:MDT) quarterly report
for quarterly period ended July 31, 2026